This company is developing gene therapies for muscle growth, erectile dysfunction, and “radical longevity”
MIT Technology Review Narrated
00:00
Expert concerns about VEGF risks
Seppo Lahirtele warns VEGF dosing and location matter, citing edema and off-target effects risks.
Play episode from 06:28
Transcript
